V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001504 | 240010108 | 1.73 | 72.6 | 03 | null | 2018-05-20 | null | 02 | N | AZACITIDINE | 101231374 |
| 240001506 | 240010109 | 1.78 | 96.7 | null | null | 2018-01-27 | null | null | N | BENDAMUSTINE + RITUXIMAB | 100048313 |
| 240001521 | 240010111 | null | null | null | 2017-06-12 | 2017-06-13 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100731628 |
| 240001525 | 240010113 | 1.71 | 74 | Palliative (P) | null | 2018-12-19 | null | 02 | null | TRIAL UNSPECIFIED | 101430017 |
| 240001526 | 240010114 | 1.57 | 63.8 | Adjuvant (A) | null | 2020-06-28 | null | 01 | N | AML19 TRIAL | 100399158 |
| 240001531 | 240010116 | 1.47 | 79 | null | null | 2021-02-23 | null | N | null | CHOP R | 101797131 |
| 240001549 | 240010121 | 1.68 | 49.7 | Palliative (P) | 2019-04-25 | 2019-04-28 | Rituximab | null | N | RITUXIMAB | 101517346 |
| 240001556 | 240010123 | 0 | 118 | null | null | 2022-05-21 | null | 01 | null | METHOTREXATE | 101537989 |
| 240001557 | 240010124 | null | null | Curative (C) | 2021-05-22 | 2021-05-24 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100744942 |
| 240001567 | 240010126 | 1.66 | 56.8 | Palliative (P) | null | 2021-07-02 | null | N | N | AML18 TRIAL | 101375329 |
| 240001588 | 240010128 | 1.76 | 45 | null | 2019-06-20 | 2019-06-20 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100106474 |
| 240001596 | 240010129 | null | null | Curative (C) | 2018-09-09 | 2018-09-10 | Hydroxycarbamide | null | null | HYDROXYCARBAMIDE | 101751354 |
| 240001597 | 240010130 | 1.85 | 92.7 | null | 2021-03-25 | 2021-03-25 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101218337 |
| 240001607 | 240010132 | 1.51 | 104.4 | null | null | 2019-11-21 | null | 02 | N | TRIAL UNSPECIFIED | 101050569 |
| 240001609 | 240010133 | null | null | null | 2018-10-17 | 2018-10-17 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101479385 |
| 240001610 | 240010134 | 1.6 | 65.8 | Palliative (P) | null | 2020-08-05 | null | N | null | METHOTREXATE | 100391470 |
| 240001617 | 240010137 | null | null | null | 2017-05-24 | 2017-05-25 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100803606 |
| 240001622 | 240010138 | 1.91 | 61.9 | 03 | null | 2022-04-25 | null | 02 | null | RITUXIMAB | 101626772 |
| 240001628 | 240010139 | 1.73 | 90.7 | 03 | null | 2021-07-29 | null | 02 | null | AML18 TRIAL | 100519114 |
| 240001635 | 240010142 | null | null | null | null | 2021-09-12 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101189247 |
| 240001645 | 240010144 | 1.6 | 71.1 | 03 | 2019-01-04 | 2019-01-08 | AML 18 TRIAL | 02 | null | AML19 TRIAL | 100762540 |
| 240001661 | 240010145 | 1.7 | 61.6 | Curative (C) | null | 2019-09-20 | null | 02 | null | AZACITIDINE | 100464255 |
| 240001666 | 240010146 | 1.78 | 70 | Curative (C) | 2018-05-22 | 2018-06-20 | Rituximab | 02 | N | RITUXIMAB | 100556397 |
| 240001667 | 240010147 | 1.8 | 77 | Curative (C) | null | 2021-12-02 | null | 02 | N | BENDAMUSTINE + RITUXIMAB | 101239835 |
| 240001716 | 240010151 | 1.62 | 76 | null | 2019-06-13 | 2019-06-13 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100707598 |
| 240001737 | 240010154 | 1.58 | 76.9 | Palliative (P) | null | 2022-03-28 | null | 02 | N | CHOP R | 101184841 |
| 240001749 | 240010155 | 1.47 | 62 | null | null | 2018-01-09 | null | 02 | null | AZACITIDINE | 101345435 |
| 240001752 | 240010156 | 0 | 70 | null | null | 2016-06-27 | null | 02 | N | CYTARABINE | 100234926 |
| 240001757 | 240010157 | 1.68 | 84.8 | null | 2017-02-16 | 2017-02-19 | AML 18 TRIAL | null | null | AML18 TRIAL | 101390699 |
| 240001766 | 240010158 | 1.69 | 67.3 | Curative (C) | null | 2020-08-28 | null | null | N | RITUXIMAB | 101006849 |
| 240001789 | 240010160 | 0 | 45.8 | Adjuvant (A) | 2017-05-07 | 2017-05-25 | CNS LGG2004 03 vinc + carbo | 02 | N | UKALL2011 | 101089934 |
| 240001816 | 240010164 | 1.69 | 89.5 | null | 2019-06-15 | 2019-06-22 | IPILIMUMAB + NIVOLUMAB | 02 | N | AML16 TRIAL | 101132644 |
| 240001823 | 240010166 | 1.67 | 93.8 | null | 2018-08-12 | 2018-08-24 | null | N | null | UKALL2014 | 100380250 |
| 240001837 | 240010167 | 1.79 | 62.3 | null | null | 2021-12-17 | AML Interim Guidelines FLAG-Ida | null | null | CYCLOPHOSPHAMIDE | 100257094 |
| 240001858 | 240010170 | 1.61 | 124.6 | Curative (C) | 2019-06-15 | 2019-06-17 | R CODOX M | 02 | null | AML DOWNS IT CYTARABINE | 100599723 |
| 240001877 | 240010172 | null | 52.95 | null | 2019-04-22 | 2019-07-18 | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100172582 |
| 240001880 | 240010173 | 1.65 | 90.8 | Curative (C) | null | 2019-09-24 | null | null | N | AML DOWNS IT CYTARABINE | 100432978 |
| 240001882 | 240010174 | 1.83 | 69.6 | Palliative (P) | 2019-02-01 | 2019-02-09 | Alemtuzumab + Cyclophos TBI Allo | 02 | N | FLAIR TRIAL | 100051396 |
| 240001888 | 240010175 | 1.61 | 66.3 | Curative (C) | null | 2021-07-22 | ALL UKALL2011 Maintenance B4 | null | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100524121 |
| 240001892 | 240010176 | 1.6 | 113 | Palliative (P) | null | 2020-05-23 | Bortezomib +/- Dexamethasone | N | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100899672 |
| 240001895 | 240010177 | 1.84 | 61.5 | Palliative (P) | null | 2019-11-30 | DA 3+8 | null | null | AML MYECHILD 01 FLA | 100246995 |
| 240001905 | 240010178 | 1.86 | 55.3 | Curative (C) | null | 2022-05-06 | R CODOX M | N | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100784879 |
| 240001909 | 240010179 | null | 28.25 | Palliative (P) | null | 2020-01-31 | AML Downs HA | N | N | PEG INTERFERON | 101780842 |
| 240001912 | 240010180 | null | 24 | null | 2021-12-30 | 2022-01-01 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | null | MIDOSTAURIN | 100060591 |
| 240001922 | 240010181 | 1.8 | 64.4 | Curative (C) | null | 2020-01-14 | CYCLOPHOSPHAMIDE + FLUDARABINE | null | null | AML MYECHILD 01 IT CYT | 101630483 |
| 240001929 | 240010182 | 1.6 | null | null | null | 2022-05-24 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | CYTARABINE + ETOPOSIDE + LOMUSTINE + MELPHALAN | 100551932 |
| 240001939 | 240010183 | 1.76 | 28.05 | null | 2020-10-12 | 2020-12-25 | DA 3 + 10 | 02 | null | CNS LOW GRADE GLIOMA VINBLASTINE | 100741940 |
| 240001943 | 240010184 | 1.53 | null | Curative (C) | 2021-05-05 | 2021-05-24 | Brentuximab | 02 | N | PEG INTERFERON | 100562552 |
| 240001972 | 240010187 | 1.53 | 83.8 | 03 | 2018-06-18 | 2018-06-21 | null | 02 | N | CISPLATIN + GEMCITABINE | 100926859 |
| 240001977 | 240010188 | 1.68 | 70 | null | 2019-01-24 | 2022-05-12 | null | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100102552 |